Used primarily in peptide synthesis as a protected amino acid building block, this compound enables the introduction of a trifluoromethylated side chain into peptide structures. The Fmoc group provides orthogonal protection for the amine, allowing stepwise assembly of peptides using solid-phase synthesis techniques. Its stability under acidic conditions and cleavage under mild basic conditions (e.g., piperidine) makes it compatible with standard Fmoc-strategy protocols. The trifluorobutanoic acid moiety can influence peptide conformation, metabolic stability, and lipophilicity, making it valuable in medicinal chemistry for optimizing pharmacokinetic properties. It is also employed in the development of enzyme inhibitors and bioactive molecule design where fluorination enhances binding affinity or resistance to degradation.